Scimitar Equity, LLC is an independent equity research firm focused on providing value-added intelligence and insightful investment conclusions on emerging companies demonstrating real progress toward their vision while meeting quarterly expectation.
RegMed Daily, Closing Bell, 2/13/12, stocks kicked off the week ending higher, as the market digests good news
End of Day, Cause and Effect
EOD Commentary: Stocks kicked off the week on a high note Monday, after Greece’s parliament finally gave the green light over the weekend to austerity measures aimed at securing an international bailout package. This week is critical as to whether the rally can sustain itself. The market is going … to have continued choppiness and …. we won’t know what to expect.
Closing Bell: The NASDAQ closed UP +27.51 (+0.95%) to 2,931.39. The Dow closed UP +72.81 (+0.57%) to 12,874.04.
Who’s up … at the close:
- Aastrom (ASTM) +$0.01 <+o.55%> to $1.84;
- Athersys (ATHX) +$0.06 <+3.24%> to $1.91;
- BioMimetic (BMTI) +$0.05 <+2.35%> to $2.18;
- Biotime (Amex: BTX) +$0.10 <+1.75%> to $5.81;
- Cytori (CYTX) +$0.08 <+2.20%> to $3.72;
- Dendreon (DNDN) +$0.41 <+2.92%> to $14.46;
- Geron (GERN) +$0.02 <+1.25%> to $2.02;
- ImmunoCellular (OTC BB: IMUC) +$0.11 <+5.82%> to $2.00;
- NeoStem (Amex: NBS) +$0.01 <+1.41%> to $0.69;
- Opexa (OPXA) +$0.12 <+12.37%> to $1.09;
- Neuralstem (Amex: CUR) +$0.04 <+3.31%> to $1.25;
- StemCells (STEM) +$0.07 <+7%> to $1.07;
- Tengion (TNGN) +$0.08 <+12.60%> to $0.715 and
- Verastem (VSTM) +$0.42 <+3.85%> to $11.32.
Register here to be notified of future Scimitar Equity articles.
